Featured Research

from universities, journals, and other organizations

New DNA-Based Vaccine Used To Fight Cancer

Date:
November 20, 1998
Source:
University Of Illinois At Chicago
Summary:
A promising new DNA-based vaccine that fights several forms of cancer has been developed by Edward Cohen, professor of microbiology and immunology at the University of Illinois at Chicago

A promising new DNA-based vaccine that fights several forms of cancer has been developed by Edward Cohen, professor of microbiology and immunology at the University of Illinois at Chicago.

Related Articles


"While this new treatment is not likely to cure the disease, we are hopeful it will extend the lives of cancer patients," says Cohen.

The vaccine will be used to treat breast, head/neck and cervical cancer and melanoma.

Cohen and his colleagues Tapas Das Gupta, professor and head of the department of surgical oncology, Barry Wenig, director of the division of head and neck surgery, and Joseph Connor, professor of obstetrics and gynecology, hope to begin Phase I human trials next year. They are actively looking for corporate sponsorship to support the trials. A patent for the technology was recently issued to the university.

The new vaccine involves the genetic modification of special types of cells to produce interleukin 2, a natural substance of the body that increases immunity to a wide variety of bacteria and viruses. The process is tailored to each patient by introducing DNA from the patient's tumor into the cells, where it can produce antigens that characterize the patient's cancer. The number of genetically modified cells is expanded and then administered to the patient as a vaccine. There are three main advantages to this treatment. First, only a small amount of tumor is needed to obtain the DNA. Second, the DNA from the tumor specifies an array of tumor antigens-this is important because tumor cells differ in their antigenic properties and by expressing as many antigens as possible, one can increase the chance of effectively treating the tumor. Third, because the DNA is placed in the cells, it becomes incorporated and is replicated as the cells divide.

"In every patient, tumor antigens are unique to that person's cancer," says Cohen. "This vaccine allows us to create specialized therapy for each patient using cells from their own body."

The therapy stimulates an immune response to the patient's tumor. Unlike chemotherapy and radiation, the treatment has been found to be non-toxic in pre-clinical studies.

One day, "this type of tumor vaccine will become an important part of the care of the cancer patient," says Cohen.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "New DNA-Based Vaccine Used To Fight Cancer." ScienceDaily. ScienceDaily, 20 November 1998. <www.sciencedaily.com/releases/1998/11/981119175231.htm>.
University Of Illinois At Chicago. (1998, November 20). New DNA-Based Vaccine Used To Fight Cancer. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/1998/11/981119175231.htm
University Of Illinois At Chicago. "New DNA-Based Vaccine Used To Fight Cancer." ScienceDaily. www.sciencedaily.com/releases/1998/11/981119175231.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins